Note that some links may require subscriptions.
Are high-profile advocates of merely rebranding eating disorders? (The Guardian)
Richard Sackler, MD, the former president of Purdue Pharma, embraced a from physicians back in 1997, agreeing with the company's head of sales that revealing its potency would be "extremely dangerous at this early stage in the life of the product," according to sealed testimony obtained by STAT News and ProPublica.
A triennial study found a in 2017, with 43.9% exhibiting at least one burnout symptom compared with 54.4% in 2014 and 45.5% in 2011. (Mayo Clinic Proceedings)
U.S. have lit up with a dramatic increase in calls about kratom exposures. (CBS News)
After her son died of an overdose, a woman in Delaware used social media to share a photo of her at a morgue, hoping that it encourages others to "stop walking around blindly" about the opioid epidemic. (Fox News)
A Texas nurse created a public database of , saying silence on the issue "is deafening." (ABC News)
Google unveiled a in their maps app to identify authorized prescription drug disposal sites.
A in Madagascar has caused or contributed to 900 deaths since last September, most of whom were young children. (NBC News)
Meanwhile, YouTube continues to promote . (BuzzFeed)
If states don't fix loopholes in vaccination laws, FDA Commissioner Scott Gottlieb, MD, said the . (CNN)
Catalyst Pharmaceuticals defended its $375,000 price tag for amifampridine (Firdapse), a new therapy for the rare neurological disorder Lambert-Eaton myasthenic syndrome, saying the price was . (Reuters)
Reflecting the dramatic growth of an emerging industry, DoorDash has a current estimated value of $7.1 billion. (Axios)
Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the ľֱ community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com